We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Smart Patch Prevents Fatal Blood Clots in Mouse Model

By Gerald M. Slutzky, PhD
Posted on 09 Dec 2016
Print article
Image: A diagram of thrombin-responsive patch that releases heparin in response to thrombin (Photo courtesy of Yuqi Zhang).
Image: A diagram of thrombin-responsive patch that releases heparin in response to thrombin (Photo courtesy of Yuqi Zhang).
Tests on a mouse model of thrombosis showed that a novel "smart patch" heparin delivery system prevented clotting efficiently in a feedback-controlled manner.

An interdisciplinary team of researchers at North Carolina State University (Raleigh, USA) and the University of North Carolina (Chapel Hill, USA) had designed a smart patch comprising microneedles made of a polymer composed of hyaluronic acid (HA) and heparin.

The polymer was designed to be responsive to thrombin, an enzyme that initiates clotting in the blood. Elevated levels of thrombin in the bloodstream dissolved the amino acid chains binding heparin to HA, releasing the heparin into the blood stream.

In a paper published in the November 25, 2016, online edition of the journal Advanced Materials, the investigators described testing the smart patch on mice. Mice were either left untreated, injected with heparin, or treated with the HA-heparin smart patch 10 minutes or six hours before being injected with a lethal dose of thrombin.

All of the mice with the HA-heparin smart patch survived both treatments. Mice injected with heparin survived the 10-minute exposure, but around 80% died after six hours. All the untreated mice were killed by both treatments.

"Our goal was to generate a patch that can monitor a patient's blood and release additional drugs when necessary; effectively, a self-regulating system," said senior author Dr. Zhen Gu, assistant professor in the joint biomedical engineering program at North Carolina State University and the University of North Carolina. "We are excited about the possibility of using a closed-loop, self-regulating smart patch to help treat a condition that affects thousands of people every year, while hopefully also driving down treatment costs. This paper represents a good first step, and we are now looking for funding to perform additional preclinical testing."

Related Links:
North Carolina State University
University of North Carolina

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.